(RMS) Hermes International SCA - Overview
Stock: Leather Goods, Ready-To-Wear, Accessories, Silk, Perfume
Dividends
| Dividend Yield | 1.03% |
| Yield on Cost 5y | 3.00% |
| Yield CAGR 5y | 54.61% |
| Payout Consistency | 96.8% |
| Payout Ratio | 37.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.1% |
| Relative Tail Risk | -5.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.13 |
| Alpha | -32.62 |
| Character TTM | |
|---|---|
| Beta | 0.352 |
| Beta Downside | 0.273 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.74% |
| CAGR/Max DD | 0.25 |
Description: RMS Hermes International SCA January 26, 2026
Hermès International SCA (ticker RMS) is a French luxury conglomerate that designs, manufactures, and sells a broad portfolio of high-end products, ranging from leather goods, ready-to-wear, accessories, silk textiles, and perfume to watches and tableware. Its value chain includes vertically integrated activities such as tanning, weaving, engraving, and metal-part production, and it distributes primarily through its own network of boutiques across Europe, Asia-Pacific, the Americas, and the Middle East.
Key recent metrics (FY 2023, disclosed 28 Feb 2024): revenue €12.6 bn (+13 % YoY), operating margin 30.8 % (up from 27.5 % in 2022), and net profit €4.0 bn, reflecting strong demand in Asia-Pacific (+18 % YoY) and resilient performance in the United States despite a 3 % slowdown in discretionary spending. The luxury sector’s global growth rate is projected at 5-6 % CAGR through 2028, driven by rising affluent consumer bases in China and India, while the European luxury market remains a modest 1-2 % growth environment (McKinsey 2023). Hermès’ same-store sales in China grew 22 % YoY, a key driver of its overall earnings expansion.
Given the company’s high operating leverage and consistent cash-generation, a quantitative deep-dive-such as a discounted cash-flow or comparable-company analysis-can help gauge whether the current market price fully reflects its growth runway; you might start that exploration on ValueRay for up-to-date valuation multiples and scenario modeling.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 6.85b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.41 > 0.02 and ΔFCF/TA 23.53 > 1.0 |
| NWC/Revenue: 48.18% < 20% (prev 80.62%; Δ -32.44% < -1%) |
| CFO/TA 0.45 > 3% & CFO 9.83b > Net Income 6.85b |
| Net Debt (-8.26b) to EBITDA (10.82b): -0.76 < 3 |
| Current Ratio: 4.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.0m) vs 12m ago 0.02% < -2% |
| Gross Margin: 68.88% > 18% (prev 0.70%; Δ 6818 % > 0.5%) |
| Asset Turnover: 109.8% > 50% (prev 65.67%; Δ 44.11% > 0%) |
| Interest Coverage Ratio: 112.8 > 6 (EBITDA TTM 10.82b / Interest Expense TTM 85.0m) |
Altman Z'' 10.00
| A: 0.51 (Total Current Assets 14.37b - Total Current Liabilities 3.19b) / Total Assets 21.83b |
| B: 0.10 (Retained Earnings 2.25b / Total Assets 21.83b) |
| C: 0.45 (EBIT TTM 9.59b / Avg Total Assets 21.14b) |
| D: 3.31 (Book Value of Equity 17.23b / Total Liabilities 5.21b) |
| Altman-Z'' Score: 10.21 = AAA |
Beneish M -2.90
| DSRI: 0.61 (Receivables 506.0m/482.0m, Revenue 23.20b/13.43b) |
| GMI: 1.02 (GM 68.88% / 69.99%) |
| AQI: 1.10 (AQ_t 0.13 / AQ_t-1 0.12) |
| SGI: 1.73 (Revenue 23.20b / 13.43b) |
| TATA: -0.14 (NI 6.85b - CFO 9.83b) / TA 21.83b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of RMS shares?
Over the past week, the price has changed by +1.28%, over one month by -4.06%, over three months by +0.59% and over the past year by -24.73%.
Is RMS a buy, sell or hold?
What are the forecasts/targets for the RMS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2374.3 | 15.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2127.1 | 3.5% |
RMS Fundamental Data Overview February 03, 2026
P/E Trailing = 47.6883
P/E Forward = 42.3729
P/S = 13.5686
P/B = 12.7999
P/EG = 4.4228
Revenue TTM = 23.20b EUR
EBIT TTM = 9.59b EUR
EBITDA TTM = 10.82b EUR
Long Term Debt = 30.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 336.0m EUR (from shortTermDebt, last quarter)
Debt = 2.06b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -8.26b EUR (from netDebt column, last quarter)
Enterprise Value = 206.70b EUR (213.03b + Debt 2.06b - CCE 8.39b)
Interest Coverage Ratio = 112.8 (Ebit TTM 9.59b / Interest Expense TTM 85.0m)
EV/FCF = 23.06x (Enterprise Value 206.70b / FCF TTM 8.96b)
FCF Yield = 4.34% (FCF TTM 8.96b / Enterprise Value 206.70b)
FCF Margin = 38.63% (FCF TTM 8.96b / Revenue TTM 23.20b)
Net Margin = 29.52% (Net Income TTM 6.85b / Revenue TTM 23.20b)
Gross Margin = 68.88% ((Revenue TTM 23.20b - Cost of Revenue TTM 7.22b) / Revenue TTM)
Gross Margin QoQ = 66.27% (prev none%)
Tobins Q-Ratio = 9.47 (Enterprise Value 206.70b / Total Assets 21.83b)
Interest Expense / Debt = 1.26% (Interest Expense 26.0m / Debt 2.06b)
Taxrate = 35.13% (1.23b / 3.50b)
NOPAT = 6.22b (EBIT 9.59b * (1 - 35.13%))
Current Ratio = 4.50 (Total Current Assets 14.37b / Total Current Liabilities 3.19b)
Debt / Equity = 0.12 (Debt 2.06b / totalStockholderEquity, last quarter 16.60b)
Debt / EBITDA = -0.76 (Net Debt -8.26b / EBITDA 10.82b)
Debt / FCF = -0.92 (Net Debt -8.26b / FCF TTM 8.96b)
Total Stockholder Equity = 16.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 32.40% (Net Income 6.85b / Total Assets 21.83b)
RoE = 42.68% (Net Income TTM 6.85b / Total Stockholder Equity 16.05b)
RoCE = 59.64% (EBIT 9.59b / Capital Employed (Equity 16.05b + L.T.Debt 30.0m))
RoIC = 37.98% (NOPAT 6.22b / Invested Capital 16.37b)
WACC = 7.15% (E(213.03b)/V(215.09b) * Re(7.21%) + D(2.06b)/V(215.09b) * Rd(1.26%) * (1-Tc(0.35)))
Discount Rate = 7.21% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.01%
[DCF Debug] Terminal Value 84.08% ; FCFF base≈6.81b ; Y1≈8.40b ; Y5≈14.31b
Fair Price DCF = 2863 (EV 291.90b - Net Debt -8.26b = Equity 300.16b / Shares 104.8m; r=7.15% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 3.56 | EPS CAGR: -52.63% | SUE: 0.0 | # QB: 0
Revenue Correlation: 98.31 | Revenue CAGR: 37.73% | SUE: 0.87 | # QB: 1
EPS next Year (2026-12-31): EPS=47.33 | Chg30d=-0.763 | Revisions Net=-6 | Growth EPS=+11.9% | Growth Revenue=+7.8%